ClinicalTrials.Veeva

Menu

Primary Tumor Depth of Invasion and Lymph Node Management in Oral Squamous Cell Carcinoma

A

Al-Azhar University

Status

Not yet enrolling

Conditions

Squamous Cell Carcinoma Mouth

Treatments

Diagnostic Test: MRI
Diagnostic Test: Histo-Pathological examination of the resected tumor tissues

Study type

Observational

Funder types

Other

Identifiers

NCT07127614
1008/2042

Details and patient eligibility

About

To evaluate the diagnostic accuracy of preoperative MRI in the determination of the primary tumor depth of invasion (DOI) as a predictor factor in neck lymph nodes management in T1T2N0 oral cavity squamous cell carcinomas as compared to the pathological depth of invasion

Full description

A diagnostic accuracy study comparing preoperative MRI scans to pathological examination of the resected oral squamous cell carcinoma with lymph nodes to determine the depth of invasion.

Enrollment

25 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with biopsy-proven oral squamous cell carcinoma with the edition T1or T2 N0 based on TNM staging by the American Joint Cancer Center AJCC 8th edition
  • The primary tumor has a depth of invasion (DOI) greater than 4 mm
  • Clinical N0 status confirmed by reasonable parameters includes computed tomography CT, MRI, -Ultrasonography,( US fine needle aspiration in suspected lymph nodes )
  • The primary tumor must be reliably resected to a clear margin without the need for entry of the neck for reconstruction

Exclusion criteria

  • Patients with T3T4 OCSCC
  • Proven or suspected positive neck node
  • Patient with distant metastasis
  • Patient with gross injury to the neck that precludes proper surgical dissection.
  • Patient with a history of radiotherapy to the neck
  • Recurrent cases of OCSCC or recurrent node disease
  • Patient with previous neck node biopsy or previous neck dissection
  • Patient with a medical condition or performance that interferes with the surgical intervention as judged by the specialist physician

Trial design

25 participants in 1 patient group

study group
Description:
Patients with biopsy proven oral squamous cell carcinoma with the edition T1or T2 N0 based on TNM staging by American Joint cancer center AJCC 8th edition
Treatment:
Diagnostic Test: Histo-Pathological examination of the resected tumor tissues
Diagnostic Test: MRI

Trial contacts and locations

1

Loading...

Central trial contact

Islam M Ali, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems